ECEda Ciftci

Eda Ciftci

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Eda Ciftci has a total of 69 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Annexin V‐Functionalized Injectable Calcium‐Deficient Hydroxyapatite for Extracellular Vesicles Binding and Controlled Release

    by Eda Ciftci, Sefa Burak Cam, Feza Korkusuz, Emre Erdem, Feray Bakan Misirlioglu, Petek Korkusuz

    Calcium phosphates alone have a limited induction potential in challenging bone conditions, necessitating strategies that enhance cellular responses and matrix‐related processes. An injectable formulation combining calcium‐deficient hydroxyapatite (CDHA) with mesenchymal stem cell‐derived extracellular vesicles may present a promising approach for modulating osteogenic activity. A dual formulation composed of calcium‐deficient HA and human bone marrow mesenchymal stem cell‐derived extracellular vesicles, incorporating Annexin V as a binding molecule, was generated and validated. Structural and molecular characterization was performed using Raman spectroscopy, electron paramagnetic resonance, and sodium dodecyl‐sulfate polyacrylamide gel electrophoresis (SDS‐PAGE). Real‐time impedance‐based cell proliferation analysis was applied to determine biologically effective concentrations. The effects of the formulation on human osteoblast behavior and early osteogenic activity were additionally evaluated. Raman spectroscopy confirmed structural integration within the formulation termed CHAnEx, showing peak shifts and spectral features at 959, 630, and 806 cm −1 , indicating molecular interactions between calcium‐deficient HA, Annexin V, and extracellular vesicles. Electron paramagnetic resonance (EPR) analysis revealed distinct g‐factor shifts consistent with binding interactions. Real‐time proliferation analysis identified biologically effective concentrations of calcium‐deficient HA and extracellular vesicles using human osteoblast models. The combined formulation increased alkaline phosphatase activity, showing approximately a 20%–25% increase compared to control groups. These findings indicate that the calcium‐deficient HA‐extracellular vesicle formulation supports functional interactions and modulates osteoblast responses under in vitro conditions, suggesting its relevance as an injectable biomaterial platform.

  • Design of poly(vinyl pyrrolidone) and poly(ethylene glycol) microneedle arrays for delivering glycosaminoglycan, chondroitin sulfate, and hyaluronic acid

    by Andisheh Choupani, Elif Sevval Temucin, Eda Ciftci, Feray Bakan, Busra Tugba Camic, Guralp Ozkoc, Meltem Sezen, Petek Korkusuz, Feza Korkusuz, Bekir Bediz

    Diabetes mellitus (DM) is a multifactorial life-threatening endocrine disease characterized by abnormalities in glucose metabolism. It is a chronic metabolic disease that involves multiple enzymes such as alpha-amylase and alpha-glucosidases. Inhibition of these enzymes has been identified as a promising method for managing diabetes, and researchers are currently focusing on discovering novel alpha-amylase and alpha-glucosidase inhibitors for diabetes therapy. Hence, we have selected 12 bioactive compounds from the Momordica charantia (MC) plant and performed a virtual screening and molecular dynamics investigation to identify natural inhibitors of alpha-amylase and alpha-glucosidases. Our in silico result revealed that phytocompound Rutin showed the highest binding affinity against alpha-amylase (1HNY) enzymes at (-11.68 kcal/mol), followed by Karaviloside II (-9.39), Momordicoside F (-9.19), Campesterol (-9.11. While docking against alpha-glucosidases (4J5T), Rutin again showed the greatest binding affinity (-11.93 kcal/mol), followed by Momordicine (-9.89), and Campesterol (-8.99). Molecular dynamics (MD) simulation research is currently the gold standard for drug design and discovery. Consequently, we conducted simulations of 100 nanoseconds (ns) to assess the stability of protein-ligand complexes based on parameters like RMSD, RMSF, RG, PCA, and FEL. The significance of our findings indicates that rutin from MC might serve as an effective natural therapeutic agent for diabetes management due to its strongest binding affinities with alpha-amylase and alpha-glucosidase enzymes. Further research in animals and humans is essential to validate the efficacy of these drug molecules.


  • Open Access

    Allogeneic bone marrow mesenchymal stem cell-derived exosomes alleviate human hypoxic AKI-on-a-Chip within a tight treatment window

    by Sefa Burak Çam, Eda Çiftci, Nazlıhan Gürbüz, Bülent Altun, Petek Korkusuz

    Background: Acute hypoxic proximal tubule (PT) injury and subsequent maladaptive repair present high mortality and increased risk of acute kidney injury (AKI) - chronic kidney disease (CKD) transition. Human bone marrow mesenchymal stem cell-derived exosomes (hBMMSC-Exos) as potential cell therapeutics can be translated into clinics if drawbacks on safety and efficacy are clarified. Here, we determined the real-time effective dose and treatment window of allogeneic hBMMSC-Exos, evaluated their performance on the structural and functional integrity of 3D microfluidic acute hypoxic PT injury platform. Methods: hBMMSC-Exos were isolated and characterized. Real-time impedance-based cell proliferation analysis (RTCA) determined the effective dose and treatment window for acute hypoxic PT injury. A 2-lane 3D gravity-driven microfluidic platform was set to mimic PT in vitro. ZO-1, acetylated α-tubulin immunolabelling, and permeability index assessed structural; cell proliferation by WST-1 measured functional integrity of PT. Results: hBMMSC-Exos induced PT proliferation with ED50 of 172,582 µg/ml at the 26th hour. Hypoxia significantly decreased ZO-1, increased permeability index, and decreased cell proliferation rate on 24–48 h in the microfluidic platform. hBMMSC-Exos reinforced polarity by a 1.72-fold increase in ZO-1, restored permeability by 20/45-fold against 20/155 kDa dextran and increased epithelial proliferation 3-fold compared to control. Conclusions: The real-time potency assay and 3D gravity-driven microfluidic acute hypoxic PT injury platform precisely demonstrated the therapeutic performance window of allogeneic hBMMSC-Exos on ischemic AKI based on structural and functional cellular data. The novel standardized, non-invasive two-step system validates the cell-based personalized theragnostic tool in a real-time physiological microenvironment prior to safe and efficient clinical usage in nephrology.


  • Open Access

    A pilot study: Nano‐hydroxyapatite‐PEG/PLA containing low dose rhBMP2 stimulates proliferation and osteogenic differentiation of human bone marrow derived mesenchymal stem cells

    by Eda Çiftci Dede, Merve Gizer, Feza Korkusuz, Zeynep Bal, Hiroyuki Ishiguro, Hideki Yoshikawa, Takashi Kaito, Petek Korkusuz

    Background: Bone morphogenetic protein 2 (BMP2) can enhance posterolateral spinal fusion (PLSF). The minimum effective dose that may stimulate mesenchymal stem cells however remains unknown. Nano‐hydroxyapatite (nHAp) polyethylene glycol (PEG)/polylactic acid (PLA) was combined with recombinant human BMP2 (rhBMP2). We in vitro evaluated proliferation, differentiation, and osteogenic genes of human bone marrow mesenchymal stem cells with 0.5, 1.0, and 3.0 μg/mL rhBMP2 doses in this study.Methods: In vitro experimental study was designed to proliferation by a real‐time quantitative cell analysis system and the osteogenic differentiation by alkaline phosphatase (ALP) activity and osteogenic marker (Runx2, OPN, and OCN) gene expressions of human derived bone marrow mesenchymal stem cells (hBMMSCs). nHAp was produced by wet chemical process and characterized by Fourier transform infrared spectrophotometer, scanning electron microscopy, and energy‐dispersive x‐ray spectroscopy. PEG/PLA polymer was produced at a 51:49 molar ratio. 0.5, 1.0, and 3.0 μg/mL rhBMP2 and nHAp was combined with the polymers. hBMMSCs were characterized by multipotency assays and surface markers were assessed by flow cytometer. The hBMMSC‐rhBMP2 containing nHAp‐PEG/PLA composite interaction was evaluated by transmission electron microscopy. Proliferative effect was evaluated by real‐time proliferation analysis, and osteogenic capacity was evaluated by ALP activity assay and qPCR.Results: hBMMSC proliferation in the 0.5 μg/mL rhBMP2 + nHAp‐PEG/PLA and the 1.0 μg/mL rhBMP2 + nHAp‐PEG/PLA groups were higher compared to control. 1.0 μg/mL rhBMP2 + nHAp‐PEG/PLA and 3.0 μg/mL rhBMP2 + nHAp‐PEG/PLA containing composites induced ALP activity on days 3 and 10. 0.5 μg/mL rhBMP2 + nHAp‐PEG/PLA application stimulated Runx2 and OPN gene expressions.Conclusion: rhBMP2 + nHAp‐PEG/PLA composites stimulate hBMMSC proliferation and differentiation. The nHAp‐PEG/PLA composite with low dose of rhBMP2 may enhance bone formation in future clinical PLSF applications.


  • Open Access

    Comparative analysis of magnetically activated cell sorting and ultracentrifugation methods for exosome isolation

    by Eda Ciftci, Naz Bozbeyoglu, Ihsan Gursel, Feza Korkusuz, Feray Bakan Misirlioglu, Petek Korkusuz

    Mesenchymal stem cell-derived exosomes regulate cell migration, proliferation, differentiation, and synthesis of the extracellular matrix, giving great potential for the treatment of different diseases. The ultracentrifugation method is the gold standard method for exosome isolation due to the simple protocol, and high yield, but presents low purity and requires specialized equipment. Amelioration of technical optimization is required for quick and reliable confinement of exosomes to translate them to the clinic as cell therapeutics In this study, we hypothesized that magnetically activated cell sorting may provide, an effective, reliable, and rapid tool for exosome isolation when compared to ultracentrifugation. We, therefore, aimed to compare the efficiency of magnetically activated cell sorting and ultracentrifugation for human mesenchymal stem cell-derived exosome isolation from culture media by protein quantification, surface biomarker, size, number, and morphological analysis. Magnetically activated cell sorting provided a higher purity and amount of exosomes that carry visible magnetic beads when compared to ultracentrifugation. The particle number of the magnetically activated cell sorting group was higher than the ultracentrifugation. In conclusion, magnetically activated cell sorting presents a quick, and reliable method to collect and present human mesenchymal stem cell exosomes to clinics at high purity for potential cellular therapeutic approaches. The novel isolation and purification method may be extended to different clinical protocols using different autogenic or allogeneic cell sources.


  • Open Access

    Adrenomedullin has no effect on segmental bone defect healing but increases bone mineral density in rat model

    by Mehmet Kaymakoglu, Eda Ciftci, Petek Korkusuz, Erdi Ozdemir, Mehmet Ege Erden, Egemen Turhan

    Objective: This study aimed to investigate the effect of adrenomedullin on the healing of the segmental bone defect in a rat model. Methods: Thirty-six Wistar rats were randomly divided into 6 groups based on follow-up periods and administered a dose of adrenomedullin hormone. In each group, bilaterally, a 2-mm bone defect was created at the diaphysis of the radius. Sodium chloride solution was administered to sham groups 3 times a week for 4 and 8 weeks intraperitoneally. Adrenomedullin was administered to the study groups 3 times a week: 15 μg—4 weeks, 15 μg—8 weeks, 30 μg—4 weeks, and 30 μg—8 weeks, respectively. After euthanasia, the segmental defects were evaluated by histomorphometric [new bone area (NBA)] and microtomographic [bone volume (BV), bone surface (BS), and bone mineral density (BMD)] analyses. Results: Although the 4- and 8-week 15 μg administered study groups had higher NBA values than the other study and control groups, the histomorphometric analysis did not reveal any statistical difference between the control and study groups regarding NBA (P > .05). In microtomographic analysis, BV was higher in the 15 μg 4-week group than 30 μg 4-week group (296.9 vs. 208.5, P=.003), and BS was lower in the 30 μg 4-week group than in the 4-week control group (695.5 vs. 1334.7, P=.005), but overall, no significant difference was found between the control and study groups (P > .05). Despite these minor differences in histomorphometric and microtomographic criteria indicating new bone formation, the BMD values of the 15 μg 8-week study group showed a significant increase compared with the control group (P=.001, respectively). Conclusion: Adrenomedullin positively affected BMD at 15 μg, but this study could not show healing in the segmental defect site at different dose regimens. Further studies are needed to assess its effects on bone tissue trauma. Cite this article as: Kaymakoglu M, Ciftci E, Korkusuz P, Ozdemir E, Erden ME, Turhan E. Adrenomedullin has no effect on segmental bone defect healing but increases bone mineral density in rat model. Acta Orthop Traumatol Turc., 2023;57(5):221-228.


  • Open Access

    Comparative analysis of magnetically activated cell sorting and ultracentrifugation for exosome isolation from human mesenchymal stem cell culture supernatant

    by Eda Ciftci-Dede, Naz Bozbeyoğlu, İhsan Gürsel, Feza Korkusuz, Feray Bakan-Misirlioglu, Petek Korkusuz

    Exosomes derived from mesenchymal stem cells regulate cell migration, proliferation, differentiation, and synthesis of the extracellular matrix. The ultracentrifugation method is the gold standard for exosome isolation with its simple protocol, high exosomal yield, allowing to work with high volume of sample features, but low purity and requirement of specialized equipment. Optimal isolation does not exist yet for obtaining the exosomes derived from mesenchymal stem cells for clinical usage. We hypothesized that magnetic-activated cell sorting may provide, effective and rapid exosomes derived from human mesenchymal stem cells when compared to ultracentrifugation. We, therefore, aimed to compare the efficiency of magnetic-activated cell sorting and ultracentrifugation for human bone marrow mesenchymal stem cell-derived exosome isolation from culture media by protein quantification, surface biomarker analysis, particle size and number analysis, and morphological analysis in vitro. Magnetically activated cell sorting provided a higher purity and amount of exosome when compared to ultracentrifugation. Magnetically activated cell sorting isolated samples exhibited the presence of magnetic beads morphologically. The particle number of the magnetic-activated cell sorting group was higher than the ultracentrifugation. In conclusion, the isolation of exosomes derived from mesenchymal stem cells by magnetic-activated cell sorting presents a quick and reliable method to collect them at high purity for clinical usage.

  • Open Access

    Development and preclinical evaluation of virus‐like particle vaccine against COVID‐19 infection

    by Ismail Cem Yilmaz, Emre Mert Ipekoglu, Artun Bulbul, Nilsu Turay, Muzaffer Yildirim, Irem Evcili, Naz Surucu Yilmaz, Nese Guvencli, Yagmur Aydin, Bilgi Gungor, et al.

    Background: Vaccines that incorporate multiple SARS‐CoV‐2 antigens can further broaden the breadth of virus‐specific cellular and humoral immunity. This study describes the development and immunogenicity of SARS‐CoV‐2 VLP vaccine that incorporates the four structural proteins of SARS‐CoV‐2.Methods: VLPs were generated in transiently transfected HEK293 cells, purified by multimodal chromatography, and characterized by tunable‐resistive pulse sensing, AFM, SEM, and TEM. Immunoblotting studies verified the protein identities of VLPs. Cellular and humoral immune responses of immunized animals demonstrated the immune potency of the formulated VLP vaccine.Results: Transiently transfected HEK293 cells reproducibly generated vesicular VLPs that were similar in size to and expressing all four structural proteins of SARS‐CoV‐2. Alum adsorbed, K3‐CpG ODN‐adjuvanted VLPs elicited high titer anti‐S, anti‐RBD, anti‐N IgG, triggered multifunctional Th1‐biased T‐cell responses, reduced virus load, and prevented lung pathology upon live virus challenge in vaccinated animals.Conclusion: These data suggest that VLPs expressing all four structural protein antigens of SARS‐CoV‐2 are immunogenic and can protect animals from developing COVID‐19 infection following vaccination.